Evidence map›Paper›PMID 35963866›Full record

ArticleNature communications2022

Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing.

Daniel T Meier, Leila Rachid, Sophia J Wiedemann, Shuyang Traub, Kelly Trimigliozzi, Marc Stawiski, Loïc Sauteur, Denise V Winter, Christelle Le Foll, Catherine Brégère and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Daniel T MeierClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland. daniel.zeman@unibas.ch.ORCID 0000-0003-3348-4657
Leila RachidClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
Sophia J WiedemannClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
Shuyang TraubClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
Kelly TrimigliozziClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
Marc StawiskiClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
Loïc SauteurDepartment of Biomedicine, University of Basel, Basel, Switzerland.ORCID 0000-0002-9163-0424
Denise V WinterDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Christelle Le FollInstitute of Veterinary Physiology, University of Zurich, 8057, Zurich, Switzerland.
Catherine BrégèreDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Raphael GuzmanDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Alex OdermattDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID 0000-0002-6820-2712
Marianne Böni-SchnetzlerClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
Marc Y DonathClinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-3143-5045
University of Basel · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defective insulin processing is associated with obesity and diabetes. Prohormone convertase 1/3 (PC1/3) is an endopeptidase required for the processing of neurotransmitters and hormones. PC1/3 deficiency and genome-wide association studies relate PC1/3 with early onset obesity. Here, we find that deletion of PC1/3 in obesity-related neuronal cells expressing proopiomelanocortin mildly and transiently change body weight and fail to produce a phenotype when targeted to Agouti-related peptide- or nestin-expressing tissues. In contrast, pancreatic β cell-specific PC1/3 ablation induces hyperphagia with consecutive obesity despite uncontrolled diabetes with glucosuria. Obesity develops not due to impaired pro-islet amyloid polypeptide processing but due to impaired insulin maturation. Proinsulin crosses the blood-brain-barrier but does not induce central satiety. Accordingly, insulin therapy prevents hyperphagia. Further, islet PC1/3 expression levels negatively correlate with body mass index in humans. In this work, we show that impaired PC1/3-mediated proinsulin processing, as observed in human prediabetes, promotes hyperphagic obesity.

Indexed as

Diabetes MellitusProinsulinGenome-Wide Association StudyHumansHyperphagiaInsulinObesityProprotein Convertase 1InsulinProinsulinProprotein Convertase 1

Identifiers

PMID35963866
PMCPMC9376086
OpenAlexW4291222009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.